Fig. 5
From: An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer
Immune-cancer cell colocalization predicts long-term outcome following chemotherapy (CT), radiotherapy (RT) and hormone therapy (HT) in human epidermal growth factor receptor 2-positive (Her2+) breast cancer. Kaplan-Meier curves show differences in disease-specific survival between Her2+ patients with or without CT (a), RT (b) and HT (c). The Morisita index significantly stratifies disease-specific survival for both treated and untreated Her2+ patients, shown by CT treatment and Morisita index (d), RT treatment and Morisita index (e) and HT treatment and Morisita index (f)